[CYCC] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
26-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- 23.00%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 843 1,944 1,734 1,084 69 699 686 3.49%
PBT -13,774 -16,486 -22,649 -11,880 -15,107 -15,808 -16,678 -3.13%
Tax -1,983 -2,144 -3,243 -1,670 -1,351 -565 -657 20.19%
NP -11,791 -14,342 -19,387 -10,153 -13,186 -15,243 -16,021 -4.97%
Tax Rate - - - - - - - -
Total Cost 12,634 16,286 21,121 11,237 13,255 15,942 16,707 -4.54%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -1,398.70 -737.76 -1,118.05 -936.62 -19,110.14 -2,180.69 -2,335.42 -8.18%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -68.85 -105.72 -211.93 -160.75 -440.40 -509.10 -711.22 -32.21%
EPS Diluted -68.85 -105.72 -211.93 -160.75 -440.40 -509.10 -711.22 -32.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.